FDA Registered 503B Outsourcing Facility
Atlas is committed to improving patient safety and product consistency for office stock compounded medication in veterinary medicine. Atlas is specifically designed and operated to meet cGMP (Current Good Manufacturing Practices), the FDA’s benchmark
standard for manufacturing quality for human and veterinary pharmaceuticals.
What is a 503B Outsourcing Facility?
A new industry classification for higher quality office stock compounds.
FDA registered facilities that produce compounds under cGMP standards.
Adhere to the guidance under section 503B of the Drug Quality and Security Act and are regularly inspected by the State Boards of Pharmacy, DEA and FDA to assure compliance.
Elevate Patient Care with 503B Medications
503Bs bring unprecedented compounding quality assurance to veterinarians and their patients.
cGMP Quality assurance controls that ensure the right drug, right strength, right dos form for the right treatment every time.
At Atlas, our top priority is patient safety and product integrity for the compounds you recommend.
We are routinely inspected by the FDA, DEA and State Boards of Pharmacy to ensure compliance to cGMP standards and 503B guidance of The Drug Quality and Security Act. We leverage 17 years of compounding expertise and quality processing to deliver the
highest level of patient care and patient safety possible for each and every product we deliver.
Learn more about Atlas Pharmaceuticals at atlasdrugs.com or call 844.661.1829.